These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35908874)

  • 21. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
    Lee SW; Kuan CS; Wu LS; Weng JT
    PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.
    Cabrera-Rubio R; Garcia-Núñez M; Setó L; Antó JM; Moya A; Monsó E; Mira A
    J Clin Microbiol; 2012 Nov; 50(11):3562-8. PubMed ID: 22915614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
    Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
    J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota.
    von Rosenvinge EC; Song Y; White JR; Maddox C; Blanchard T; Fricke WF
    ISME J; 2013 Jul; 7(7):1354-66. PubMed ID: 23466701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the microbiota difference of bronchoalveolar lavage fluid between community-acquired pneumonia with or without COPD based on metagenomic sequencing: a retrospective study.
    Wang B; Tan M; Li W; Xu Q; Jin L; Xie S; Wang C
    BMC Pulm Med; 2024 Jun; 24(1):278. PubMed ID: 38867204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in bronchoalveolar lavage fluid in patients with ventilator-associated pneumonia.
    Yang XJ; Wang YB; Zhou ZW; Wang GW; Wang XH; Liu QF; Zhou SF; Wang ZH
    Drug Des Devel Ther; 2015; 9():4883-96. PubMed ID: 26345636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
    Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
    Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.
    Cui L; Lucht L; Tipton L; Rogers MB; Fitch A; Kessinger C; Camp D; Kingsley L; Leo N; Greenblatt RM; Fong S; Stone S; Dermand JC; Kleerup EC; Huang L; Morris A; Ghedin E
    Am J Respir Crit Care Med; 2015 Apr; 191(8):932-42. PubMed ID: 25603113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species-level evaluation of the human respiratory microbiome.
    Ibironke O; McGuinness LR; Lu SE; Wang Y; Hussain S; Weisel CP; Kerkhof LJ
    Gigascience; 2020 Apr; 9(4):. PubMed ID: 32298431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
    Madapoosi SS; Cruickshank-Quinn C; Opron K; Erb-Downward JR; Begley LA; Li G; Barjaktarevic I; Barr RG; Comellas AP; Couper DJ; Cooper CB; Freeman CM; Han MK; Kaner RJ; Labaki W; Martinez FJ; Ortega VE; Peters SP; Paine R; Woodruff P; Curtis JL; Huffnagle GB; Stringer KA; Bowler RP; Esther CR; Reisdorph N; Huang YJ;
    Am J Respir Crit Care Med; 2022 Aug; 206(4):427-439. PubMed ID: 35536732
    [No Abstract]   [Full Text] [Related]  

  • 34. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
    Huang YJ; Kim E; Cox MJ; Brodie EL; Brown R; Wiener-Kronish JP; Lynch SV
    OMICS; 2010 Feb; 14(1):9-59. PubMed ID: 20141328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The airway microbiota and exacerbations of COPD.
    Leiten EO; Nielsen R; Wiker HG; Bakke PS; Martinsen EMH; Drengenes C; Tangedal S; Husebø GR; Eagan TML
    ERJ Open Res; 2020 Jul; 6(3):. PubMed ID: 32904583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of microbial diversity in corrosion samples from energy transmission towers.
    Oliveira VM; Lopes-Oliveira PF; Passarini MR; Menezes CB; Oliveira WR; Rocha AJ; Sette LD
    Biofouling; 2011 Apr; 27(4):435-47. PubMed ID: 21563009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of microbiota in stable patients with chronic obstructive pulmonary disease.
    Aguirre E; Galiana A; Mira A; Guardiola R; Sánchez-Guillén L; Garcia-Pachon E; Santibañez M; Royo G; Rodríguez JC
    APMIS; 2015 May; 123(5):427-32. PubMed ID: 25858184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.
    Vázquez-Pérez JA; Carrillo CO; Iñiguez-García MA; Romero-Espinoza I; Márquez-García JE; Falcón LI; Torres M; Herrera MT
    Microb Pathog; 2020 Feb; 139():103851. PubMed ID: 31715320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.